Prevention of etomidate induced myoclonus by use of pregabali
Phase 4
Completed
- Conditions
- Health Condition 1: null- ASA grade I or II patient, Non diabetic, Nonhypertensive
- Registration Number
- CTRI/2017/03/007978
- Lead Sponsor
- Apollo Hospitals Bilaspur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.ASA grade I and II,
2.non hypertensive and non diabetic
3.scheduled for surgery under general anesthesia
Exclusion Criteria
1.patients with known sensitivity to pregabalin,
2.seizure disorders, who were taking pregabalin or gabapentin,
3.history of drug or alcohol abuse,
4.history of chronic pain or daily intake of analgesics,
5.pregnant or breast-feeding females,
6.uncontrolled medical disease (diabetes mellitus and hypertension)
7.impaired kidney or liver functions and
8.psychiatric patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method